​

Cingulate (CING) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

CING Stock Forecast

Cingulate (CING) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $11.00, with a high of $11.00 and a low of $11.00. This represents a 109.13% increase from the last price of $5.26.

- $3 $6 $9 $12 $15 High: $11 Avg: $11 Low: $11 Last Closed Price: $5.26

CING Stock Rating

Cingulate stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (83.33%), 1 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 1 5 0 Strong Sell Sell Hold Buy Strong Buy

CING Price Target Upside V Benchmarks

TypeNameUpside
StockCingulate109.13%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$11.00
Last Closing Price$5.26$5.26$5.26
Upside/Downside--109.13%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2612---3
Mar, 2612---3
Feb, 2613---4
Jan, 2613---4
Dec, 2513---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 19, 2025Boobalan PachaiyappanRoth Capital$11.00$3.82187.96%109.13%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 08, 2025Roth CapitalBuyBuyhold
May 19, 2025Roth CapitalBuyBuyhold
Jan 30, 2025H.C. WainwrightBuyBuyhold
Nov 20, 2024Maxim GroupBuyupgrade

Financial Forecast

EPS Forecast

$-350 $-270 $-190 $-110 $-30 $50 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-311.99$-10.20$-4.13---
Avg Forecast$-333.21$-10.96$-4.53$-1.39$-0.48$1.31
High Forecast$-333.21$-8.44$-1.88$-0.27$-0.48$1.31
Low Forecast$-333.21$-15.52$-6.64$-2.50$-0.48$1.31
Surprise %-6.37%-6.93%-8.83%---

Revenue Forecast

$5M $9M $13M $17M $21M $25M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$18.65M$7.77M$9.51M$21.01M
High Forecast--$18.65M$7.77M$9.51M$21.01M
Low Forecast--$18.65M$7.77M$9.51M$21.01M
Surprise %------

Net Income Forecast

$-30M $-23M $-16M $-9M $-2M $5M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-23.53M$-15.55M$-22.45M---
Avg Forecast$-25.14M$-903.95K$-321.32K$-104.48K$-36.21K$98.82K
High Forecast$-25.14M$-637.04K$-141.93K$-20.37K$-36.21K$98.82K
Low Forecast$-25.14M$-1.17M$-500.71K$-188.59K$-36.21K$98.82K
Surprise %-6.37%1619.76%6886.84%---

CING Forecast FAQ

Is Cingulate stock a buy?

Cingulate stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Cingulate is a favorable investment for most analysts.

What is Cingulate's price target?

Cingulate's price target, set by 6 Wall Street analysts, averages $11 over the next 12 months. The price target range spans from $11 at the low end to $11 at the high end, suggesting a potential 109.13% change from the previous closing price of $5.26.

How does Cingulate stock forecast compare to its benchmarks?

Cingulate's stock forecast shows a 109.13% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Cingulate over the past three months?

  • April 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Cingulate’s EPS forecast?

Cingulate's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.39, marking a -66.34% decrease from the reported $-4.13 in 2025. Estimates for the following years are $-0.48 in 2027, and $1.31 in 2028.

What is Cingulate’s revenue forecast?

Cingulate's average annual revenue forecast for its fiscal year ending in December 2026 is $7.77M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $9.51M, and $21.01M for 2028.

What is Cingulate’s net income forecast?

Cingulate's net income forecast for the fiscal year ending in December 2026 stands at $-104K, representing a -99.53% decrease from the reported $-22.45M in 2025. Projections indicate $-36.209K in 2027, and $98.82K in 2028.